wound complications and bleeding
Related entities
Findings (27)
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42
None
adverseBypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro
Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42